1. Home
  2. NWL vs IRON Comparison

NWL vs IRON Comparison

Compare NWL & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Newell Brands Inc.

NWL

Newell Brands Inc.

SELL

Current Price

$5.62

Market Cap

2.7B

Sector

Industrials

ML Signal

SELL

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

SELL

Current Price

$61.45

Market Cap

2.4B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
NWL
IRON
Founded
1903
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Plastic Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.7B
2.4B
IPO Year
1995
2020

Fundamental Metrics

Financial Performance
Metric
NWL
IRON
Price
$5.62
$61.45
Analyst Decision
Hold
Strong Buy
Analyst Count
9
13
Target Price
$6.66
★ $103.17
AVG Volume (30 Days)
★ 5.1M
591.6K
Earning Date
10-30-2026
11-05-2026
Dividend Yield
★ 4.96%
N/A
EPS Growth
★ N/A
N/A
EPS
★ 0.17
N/A
Revenue
★ $14,742,200,000.00
N/A
Revenue This Year
$1.75
N/A
Revenue Next Year
$1.48
N/A
P/E Ratio
$33.20
★ N/A
Revenue Growth
★ 11.14
N/A
52 Week Low
$3.07
$40.00
52 Week High
$7.13
$99.50

Technical Indicators

Market Signals
Indicator
NWL
IRON
Relative Strength Index (RSI) 49.18 29.13
Support Level $4.95 $58.30
Resistance Level $6.28 $82.89
Average True Range (ATR) 0.19 2.50
MACD 0.03 -0.07
Stochastic Oscillator 66.90 28.02

Price Performance

Historical Comparison
NWL
IRON

About NWL Newell Brands Inc.

Newell Brands Inc is an American consumer goods company with a portfolio of brands, including Rubbermaid, Sharpie, Graco, Coleman, Rubbermaid Commercial Products, Yankee Candle, Paper Mate, FoodSaver, Dymo, EXPO, Elmer's, Oster, NUK, Spontex and Campingaz. The group is focused on delighting consumers by lighting up everyday moments. Its segments are Home and Commercial Solutions, Learning and Development, and Outdoor and Recreation. The group geographic areas are the United States, Canada, Europe, the Middle East and Africa, Asia Pacific, and Latin America.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs), including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: